Advanced Enzyme Technologies Limited, a major player in the enzyme manufacturing sector, has released its unaudited financial results for the quarter and half year ending September 30, 2026. The announcement was made following a Board Meeting held on October 31, 2026, which ran from 10:45 a.m. to 11:35 a.m.
The Board of Directors approved the standalone and consolidated financial results as part of their agenda. Advanced Enzyme Technologies Limited has also provided a Limited Review Report from its statutory auditors, accompanying these financial results.
This latest disclosure offers a closer look into the company's performance in the recent financial period. However, specific revenue, profit, or loss figures were not detailed in the corporate announcement. Advanced Enzyme Technologies Limited's financial results are also accessible on their official website.
In addition to financial disclosures, the Board evaluated requests from certain promoter group members who wish to be reclassified as public shareholders. This move is in line with Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. The detailed requests and the board's views...